These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 17123735)
1. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Fusayasu E; Kowa H; Takeshima T; Nakaso K; Nakashima K Pain; 2007 Apr; 128(3):209-214. PubMed ID: 17123735 [TBL] [Abstract][Full Text] [Related]
2. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal. Lee MJ; Lee SY; Cho S; Kang ES; Chung CS J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780 [TBL] [Abstract][Full Text] [Related]
3. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine. Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383 [TBL] [Abstract][Full Text] [Related]
4. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Gallai V; Sarchielli P; Floridi A; Franceschini M; Codini M; Glioti G; Trequattrini A; Palumbo R Cephalalgia; 1995 Oct; 15(5):384-90. PubMed ID: 8536297 [TBL] [Abstract][Full Text] [Related]
5. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Ashina M; Bendtsen L; Jensen R; Schifter S; Olesen J Pain; 2000 May; 86(1-2):133-8. PubMed ID: 10779670 [TBL] [Abstract][Full Text] [Related]
7. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872 [TBL] [Abstract][Full Text] [Related]
8. [Effect of electroacupuncture on cortical spreading depression and plasma CGRP and substance P contents in migraine rats]. Shi H; Li JH; Ji CF; Shang HY; Qiu EC; Wang JJ; Jing XH Zhen Ci Yan Jiu; 2010 Feb; 35(1):17-21. PubMed ID: 20458901 [TBL] [Abstract][Full Text] [Related]
9. No increase of calcitonin gene-related peptide in jugular blood during migraine. Tvedskov JF; Lipka K; Ashina M; Iversen HK; Schifter S; Olesen J Ann Neurol; 2005 Oct; 58(4):561-8. PubMed ID: 16178016 [TBL] [Abstract][Full Text] [Related]
10. [Frequent episodic migraine and calcitonin gene-related peptide. Influence of treatment with topiramate and zonisamide on levels of the peptide]. Garcia-Estevez DA; Pardo-Parrado M; Silvarrey-Rodriguez S Rev Neurol; 2017 Aug; 65(4):153-156. PubMed ID: 28726232 [TBL] [Abstract][Full Text] [Related]
11. Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients. Fekrazad R; Sardarian A; Azma K; Karami M; Borhani-Haghighi A; Gharesi-Fard B; Movahedi B Neurol Sci; 2018 Jul; 39(7):1217-1223. PubMed ID: 29654418 [TBL] [Abstract][Full Text] [Related]
13. [Effect of gamma-aminobutyric acid treatment on plasma substance P and calcitonin gene-related peptide levels in children with asthma]. Xu CW; Guo SC; Zheng ZW; Wang QY Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):102-4. PubMed ID: 23428122 [TBL] [Abstract][Full Text] [Related]
14. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial. Ghorbani Z; Rafiee P; Fotouhi A; Haghighi S; Rasekh Magham R; Ahmadi ZS; Djalali M; Zareei M; Razeghi Jahromi S; Shahemi S; Mahmoudi M; Togha M J Headache Pain; 2020 Feb; 21(1):22. PubMed ID: 32093657 [TBL] [Abstract][Full Text] [Related]
15. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis. Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721 [TBL] [Abstract][Full Text] [Related]
16. Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients. Tuka B; Helyes Z; Markovics A; Bagoly T; Szolcsányi J; Szabó N; Tóth E; Kincses ZT; Vécsei L; Tajti J Cephalalgia; 2013 Oct; 33(13):1085-95. PubMed ID: 23598374 [TBL] [Abstract][Full Text] [Related]
17. Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period. Gupta R; Ahmed T; Banerjee B; Bhatia M J Headache Pain; 2009 Jun; 10(3):161-6. PubMed ID: 19277835 [TBL] [Abstract][Full Text] [Related]
18. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine. Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487 [TBL] [Abstract][Full Text] [Related]
19. Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura. Friberg L; Olesen J; Olsen TS; Karle A; Ekman R; Fahrenkrug J Cephalalgia; 1994 Feb; 14(1):47-54. PubMed ID: 7515329 [TBL] [Abstract][Full Text] [Related]
20. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls. Kamm K; Straube A; Ruscheweyh R Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]